Familial adenomatous polyposis: Aberrant splicing due to missense or silent mutations in theAPCgene
Authors:
- 30 September 2004
- journal article
- research article
- Published by Hindawi Limited in Human Mutation
- Vol. 24 (5) , 370-380
Abstract
Familial adenomatous polyposis (FAP) is caused by germline mutations in the tumor suppressor gene APC. To date, the relevance of rare exonic single-base substitutions at nucleotide positions close to splice sites that are predicted to result in missense or silent (SNP) variants or substitutions in introns at splice-site positions that are not highly conserved has not been systematically examined in FAP patients. In 34 index patients, we identified 26 different heterozygous single-base substitutions at or close to the splice sites. We characterized five exonic mutations in exon 4 (c.423G>T), exon 14 (c.1956C>T, c.1957A>G, and c.1957A>C), and exon 15 (c.1959G>A) by transcript analysis and by splice-prediction programs (BDGP, SpliceSiteFinder, and ESEfinder). The splicing patterns of these variants were compared to those of 16 different substitutions at highly or less-conserved intronic splice-site positions, and to normal controls. In addition, we analyzed cosegregation of the variants with affected family members and examined the genotype–phenotype correlation. We could demonstrate that the four unclear variants in exon 4 and 14 that are predicted to result in missense or silent mutations in fact lead to complete exon skipping due to aberrant splicing; one possible explanation for this observed effect might be the disruption of exonic splicing enhancer (ESE) motifs. In contrast, the substitution at the first position of exon 15 seems to actually be a silent variant. We present the first systematic evaluation of different single-base substitutions in APC at or close to splice sites at transcript level. We show that the consequence of exonic mutations cannot be evaluated only by the predicted change in amino acid sequence but rather by the change at DNA level. The functional analysis of variants with unknown pathogenic effect plays an important role in increasing the mutation detection rate and achieving validation of predictive testing. Hum Mutat 24:370–380, 2004.Keywords
This publication has 44 references indexed in Scilit:
- Frequency and parental origin of de novo APC mutations in familial adenomatous polyposisEuropean Journal of Human Genetics, 2003
- Characterization of disease-associated mutations affecting an exonic splicing enhancer and two cryptic splice sites in exon 13 of the cystic fibrosis transmembrane conductance regulator geneHuman Molecular Genetics, 2003
- ESEfinder: a web resource to identify exonic splicing enhancersNucleic Acids Research, 2003
- Alternative splicing: multiple control mechanisms and involvement in human diseaseTrends in Genetics, 2002
- Listening to silence and understanding nonsense: exonic mutations that affect splicingNature Reviews Genetics, 2002
- HumanBRCA1 gene rescues the embryonic lethality ofBrca1 mutant miceGenesis, 2001
- Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1Human Molecular Genetics, 2000
- Constitutive APC exon 14 skipping in early-onset familial adenomatous polyposis reveals a dramatic quantitative distortion ofAPC gene-specific isoformsHuman Mutation, 1997
- Multiple products in the protein truncation test due to alternative splicing in the adenomatous polyposis coli (APC) geneHuman Genetics, 1996
- Clinical features in familial polyposis coliDiseases of the Colon & Rectum, 1986